Insider Stock Trading History of Tierney David S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tierney David S since year 2005. The trader's CIK number is 1292636. At the time of this reporting, Tierney David S is the of Catalyst Pharmaceuticals, Inc. . (stock ticker symbol CPRX). See this page for all insider trading activities at Catalyst Pharmaceuticals, Inc. .

Note that in the past Tierney David S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Tierney David S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-09 CPRX Catalyst Pharmaceuticals, Inc. Option Ex 50,000 .47 23,500
2017-03-20 KMPH Kempharm, Inc Buy 1,000 4.20 4,200
2015-10-27 CPRX Catalyst Pharmaceuticals, Inc. Option Ex 30,000 1.09 32,700
2015-04-21 KMPH Kempharm, Inc Buy 5,000 11.00 55,000
2014-10-16 CPRX Catalyst Pharmaceuticals, Inc. Option Ex 30,000 .90 27,000
2013-10-23 CPRX Catalyst Pharmaceuticals, Inc. Buy 8,000 2.03 16,239
2012-05-29 CPRX Catalyst Pharmaceuticals, Inc. Buy 20,000 .58 11,700
2009-06-05 BJCT Bioject Medical Technologies Inc Option Ex 36,000 .00 0
2009-03-06 CPRX Catalyst Pharmaceuticals, Inc. Buy 3,000 1.55 4,650
2008-12-05 BJCT Bioject Medical Technologies Inc Option Ex 36,000 .00 0
2008-06-14 BJCT Bioject Medical Technologies Inc Option Ex 3,000 .00 0
2007-12-14 BJCT Bioject Medical Technologies Inc Option Ex 3,000 .00 0
2007-04-02 VLRX Valera Pharmaceuticals Inc Option Ex 100,000 3.00 300,000
2006-05-25 VLRX Valera Pharmaceuticals Inc Buy 1,000 7.73 7,730
2006-02-02 VLRX Valera Pharmaceuticals Inc Buy 5,500 9.00 49,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tierney David S ( of Catalyst Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.